Barry C. Ross

1.2k citations

38 papers · 905 indexed · h-index 16

Impact in

Pharmaceutical Science top 2%
- Fluorine in Organic Chemistry
Organic Chemistry top 5%
- Carbohydrate Chemistry and Synthesis

Papers in

Organic Chemistry 17
- Synthesis of β-Lactam Compounds 7
- Synthesis and Catalytic Reactions 3
- Synthesis and Biological Evaluation 3
Pharmaceutical Science 3
- Fluorine in Organic Chemistry 3

Co-authors: William B. Motherwell Matthew J. Tozer Nigel S. Watson Barry Porter Julie L. Hutson Michael Snowden Robert J. Williams J. Motteram
Journals: Tetrahedron Letters (7 papers)Journal of Medicinal Chemistry (6 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Life Sciences (2 papers)British Journal of Pharmacology (2 papers)
Partner nations: United Kingdom Germany United States

In The Last Decade

Barry C. Ross

37 papers receiving 802 citations

Peers

Countries citing papers authored by Barry C. Ross

Since Specialization

Citations

This map shows the geographic impact of Barry C. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry C. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry C. Ross more than expected).

Fields of papers citing papers by Barry C. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry C. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry C. Ross. The network helps show where Barry C. Ross may publish in the future.

Co-authors

The 25 scholars most cited alongside Barry C. Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barry C. Ross Line = papers co-authored together Barry C. Ross links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	5,5-Trans lactone-containing inhibitors of serine proteases: Identification of a novel, acylating thrombin inhibitor Bioorganic & Medicinal Chemistry Letters ·Harry Finch, Neil Pegg, Eiko Matsuhashi, Kim Junmyeoung, Mahzad Rahmani, Ordóñez Osorto, PETER M. ATKINSON, John G. Montana, Martin Owen, A. Konarkowski, B. Schrempp-Otto, Barry C. Ross, Callum J. Campbell, C. J. Dix, Christopher J. Mooney, Jonathan Cebon, Champa Patel	1998	13
2	Cardiovascular effects of GR117289, a novel angiotensin AT₁ receptor antagonist British Journal of Pharmacology ·A. Hilditch, J. Jasinski, C. Gardner, D.J. Twissell, S. Belin, A. Travers, G.M. Drew, David Middlemiss, Barry C. Ross, Mark J. Robertson	1994	21
3	Bromobenzofuran-Based Non-peptide Antagonists of Angiotensin II: GR138950, a Potent Antihypertensive Agent with High Oral Bioavailability Journal of Medicinal Chemistry ·Duncan B. Judd, Michael D. Dowle, David Middlemiss, D. I. C. SCOPES, Barry C. Ross, T. Pasilio, Martin Pass, Hiramani Patgiri, Kimia Rajabzadeh Tabari	1994	33
4	Orally Active Non-Peptide Fibrinogen Receptor (GpIIb/IIIa) Antagonists: Identification of 4-[4-[4-(Aminoimino methyl)phenyl]-1-piperazinyl]-1- piperidineacetic Acid as a Long-Acting, Broad-Spectrum Antithrombotic Agent Journal of Medicinal Chemistry ·Karen Jacobs-Lona, Brian Evans, QI Nianxia, Brian D. Judkins, Henry Ansgar Kelly, John R. Kitchin, Philip Lumley, Barry Porter, Barry C. Ross	1994	37
5	Inhibitors of cholesterol biosynthesis. 2. 3,5-Dihydroxy-7-(N-pyrrolyl)-6-heptenoates, a novel series of HMG-CoA reductase inhibitors Journal of Medicinal Chemistry ·Panayiotis A. Procopiou, 高橋繁男, Julie L. Hutson, Graham G. A. Inglis, Barry C. Ross, Nigel S. Watson	1993	24
6	A convenient strategy for replacement of the anomeric hydroxyl group by difluoromethyl functionality in carbohydrate derivatives Tetrahedron ·Shiyuan Li, William B. Motherwell, Barry C. Ross, Matthew J. Tozer, David J. Williams, Alexandra M. Z. Slawin	1993	61
7	Conformationally constrained tachykinin analogs: potent and highly selective neurokinin NK-2 receptor agonists Journal of Medicinal Chemistry ·Martyn J. Deal, Russell M. Hagan, S.J. Ireland, Christopher Jordan, Andrew B. McElroy, Barry Porter, Barry C. Ross, TAFIDA EL SAYED, P. Ward	1992	26
8	Pharmacological profile of GR117289 in vitro: a novel, potent and specific non‐peptide angiotensin AT₁ receptor antagonist British Journal of Pharmacology ·Mark J. Robertson, Jen Barnes, G.M. Drew, Kenneth L. Clark, Fiona H. Marshall, A.D. Michel, David Middlemiss, Barry C. Ross, D. I. C. SCOPES, Michael D. Dowle	1992	66
9	Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor Journal of Medicinal Chemistry ·Andrew B. McElroy, Chichi Kurniawan, Martyn J. Deal, Trevor Carnahan, Russell M. Hagan, S.J. Ireland, Christopher Jordan, Barry Porter, Barry C. Ross	1992	62
10	Synthesis of the staurosporine aglycon The Journal of Organic Chemistry ·Christopher J. Moody, بوبكر دبابى, Barry Porter, Barry C. Ross	1992	52
11	Susceptibility of carp and tilapia α-amylase to purified wheat amylase inhibitor Aquaculture ·Nicola Heather Dodd, Barry C. Ross, Liñdsay G. Ross	1992	6
12	A convenient method for replacement of the anomeric hydroxy group in carbohydrates by difluoromethyl functionality Journal of the Chemical Society Chemical Communications ·William B. Motherwell, Matthew J. Tozer, Barry C. Ross	1989	104
13	Some Radical Reactions of Exocyclic Carbohydrate Difluoroenol Ethers Synlett ·William B. Motherwell, Barry C. Ross, Matthew J. Tozer	1989	38
14	Novel peptide surrogates: The retroreduced isostere Tetrahedron Letters ·Malcolm M. Campbell, Barry C. Ross, Graeme Semple	1989	6
15	In vitro histamine H2-antagonist activity of the novel compound HUK 978 Life Sciences ·Sonia Rocío Suárez, D. B. Norris, Trevor J. Rising, Barry C. Ross, Érika Lopes Muniz da Silva	1985	5
16	Synthesis of 1,2,4,6-thiatriazine 1,1-dioxides. Part III Tetrahedron Letters ·Ávila Pulgarín, Barry C. Ross, Peter M. Rees	1985	3
17	Synthesis of a 7-oxo-1,4-diazabicyclo[3.2.0]hept-3-ene-2-carboxylate (Δ¹-azapenem) and a related 3,7-dioxo-1,4-diazabicyclo[3.2.0]heptane-2-carboxylate, a fused β,γ-lactam Journal of the Chemical Society Chemical Communications ·Graham D. Johnson, Peter M. Rees, Barry C. Ross	1984	4
18	Spirocyclic side-chain derivatives of penicillin and cephalosporin Journal of the Chemical Society Perkin Transactions 1 ·Peter G. Sammes, Prof Wadia, Barry C. Ross	1984	4
19	Stereoselective synthesis of a (5R,6S)-6-[(R)-1-hydroxyethyl]-2-thioxo-penam ester through a hydroxy group directed chlorinolysis Journal of the Chemical Society Chemical Communications ·Lingaraj Sahoo, Graham Johnson, Barry C. Ross	1983	2
20	Azapenems: synthesis of 4-substituted 7-oxo-1,4-diazabicyclo[3.2.0]-hept-2-ene carboxylates Journal of the Chemical Society Chemical Communications ·Graham Johnson, Barry C. Ross	1981	5

About Barry C. Ross

Barry C. Ross is a scholar working on Organic Chemistry, Pharmaceutical Science, Biotechnology, Pharmacology and Toxicology, having authored 38 papers that have together received 905 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (8 papers), Synthesis of β-Lactam Compounds (7 papers), Neuropeptides and Animal Physiology (5 papers), Synthesis and Catalytic Reactions (3 papers), Fluorine in Organic Chemistry (3 papers), Synthesis and Biological Evaluation (3 papers), Chemical Synthesis and Analysis (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Pharmaceutical Science (165 citations), Organic Chemistry (372 citations), Pharmacology (131 citations), Molecular Biology (505 citations) and Biotechnology (56 citations). Barry C. Ross has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include William B. Motherwell, Matthew J. Tozer, Nigel S. Watson, Barry Porter, Julie L. Hutson, Michael Snowden, Robert J. Williams, J. Motteram, A.J. Baxter and Antonio Desmond McCarthy. Their work appears in journals such as Tetrahedron Letters, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Life Sciences and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact